+

WO1998042320A3 - Prolongation de l'expression de proteines transgeniques par traitement immunomodulant avec de la 15-desoxyspergualine - Google Patents

Prolongation de l'expression de proteines transgeniques par traitement immunomodulant avec de la 15-desoxyspergualine Download PDF

Info

Publication number
WO1998042320A3
WO1998042320A3 PCT/EP1998/001439 EP9801439W WO9842320A3 WO 1998042320 A3 WO1998042320 A3 WO 1998042320A3 EP 9801439 W EP9801439 W EP 9801439W WO 9842320 A3 WO9842320 A3 WO 9842320A3
Authority
WO
WIPO (PCT)
Prior art keywords
deoxyspergualine
immunomodulation
expression
extension
transgenic proteins
Prior art date
Application number
PCT/EP1998/001439
Other languages
German (de)
English (en)
Other versions
WO1998042320A2 (fr
Inventor
Gerhard Seemann
Guenter Cichon
Original Assignee
Hoechst Ag
Gerhard Seemann
Guenter Cichon
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag, Gerhard Seemann, Guenter Cichon filed Critical Hoechst Ag
Priority to AU70344/98A priority Critical patent/AU7034498A/en
Publication of WO1998042320A2 publication Critical patent/WO1998042320A2/fr
Publication of WO1998042320A3 publication Critical patent/WO1998042320A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

L'invention concerne l'utilisation de 15-désoxyspergualine pour préparer un médicament destiné à augmenter la tolérance d'un mammifère vis-à-vis de cellules transgéniques. L'utilisation de 15-désoxyspergualine permet de prolonger de manière notoire la production du produit d'expression transgénique, même après arrêt du traitement immunosuppresseur.
PCT/EP1998/001439 1997-03-21 1998-03-12 Prolongation de l'expression de proteines transgeniques par traitement immunomodulant avec de la 15-desoxyspergualine WO1998042320A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU70344/98A AU7034498A (en) 1997-03-21 1998-03-12 Extension of the expression of transgenic proteins by immunomodulation with 15-deoxyspergualine

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19711803.8 1997-03-21
DE1997111803 DE19711803A1 (de) 1997-03-21 1997-03-21 Verlängerung der Expression von transgenen Proteinen durch immunmodulierende Behandlung mit 15-Deoxyspergualin

Publications (2)

Publication Number Publication Date
WO1998042320A2 WO1998042320A2 (fr) 1998-10-01
WO1998042320A3 true WO1998042320A3 (fr) 1998-12-23

Family

ID=7824119

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP1998/001439 WO1998042320A2 (fr) 1997-03-21 1998-03-12 Prolongation de l'expression de proteines transgeniques par traitement immunomodulant avec de la 15-desoxyspergualine

Country Status (3)

Country Link
AU (1) AU7034498A (fr)
DE (1) DE19711803A1 (fr)
WO (1) WO1998042320A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19923961A1 (de) 1999-05-25 2000-11-30 Euro Nippon Kayaku Gmbh Verwendung von 15-Deoxyspergualin zur Behandlung von hyperreaktiven entzündlichen Erkrankungen und Autoimmunerkrankungen

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996012406A1 (fr) * 1994-10-19 1996-05-02 Genetic Therapy, Inc. Therapie genique par administration concurrente et repetee d'adenovirus et d'agents immunodepresseurs
WO1997039776A1 (fr) * 1996-04-19 1997-10-30 Genetic Therapy, Inc. Therapie genique reposant sur l'administration conjointe et repetee d'adenovirus et d'agents immunosuppresseurs

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996012406A1 (fr) * 1994-10-19 1996-05-02 Genetic Therapy, Inc. Therapie genique par administration concurrente et repetee d'adenovirus et d'agents immunodepresseurs
WO1997039776A1 (fr) * 1996-04-19 1997-10-30 Genetic Therapy, Inc. Therapie genique reposant sur l'administration conjointe et repetee d'adenovirus et d'agents immunosuppresseurs

Non-Patent Citations (10)

* Cited by examiner, † Cited by third party
Title
HALLORAN, P.F.: "Rethinking Immunosuppression in Terms of the Redundant and Nonredundant Steps in the Immune Response", TRANSPLANTATION PROCEEDINGS, vol. 28, no. 6, 1996, pages 11 - 18, XP002076660 *
KALDEN ET AL.: "NEW THERAPEUTIC APPROACHES IN AUTOIMMUNE RHEUMATIC DISEASES, WITH SPECIAL EMPHASIS ON RHEUMATOID ARTHRITIS", BRITISH JOURNAL OF RHEUMATOLOGY, vol. 34, no. 3, 1995, pages 193 - 196, XP002076661 *
KERR ET AL.: "DEOXYSPERGUALIN SUPPRESSES LOCAL MACROPHAGE PROLIFERATION IN RAT RENAL ALLOGRAFT REJECTION", TRANSPLANTATION, vol. 58, no. 5, 1994, pages 596 - 601, XP002076657 *
NIKOLIC-PATERSON ET AL.: "Deoxyspergualin Inhibits Mesangial Cell Proliferation and Major Histocompatibility Complex Class II Expression", J. AM. SOC. NEPHROLOGY, vol. 5, no. 11, 1995, pages 1895 - 1902, XP002076656 *
PERICO ET AL.: "Prevention of Transplant Rejection", DRUGS, vol. 54, no. 4, 1997, pages 533 - 570, XP002076654 *
RÄISÄNEN-SOKOLOWSKI ET AL.: "Mechanism of Action of 15-Deoxyspergualin in Allograft Arteriosclerosis in Rat Aortic Transplants", TRANSPLANTATION PROCEEDINGS, vol. 26, no. 5, 1994, pages 3224, XP002076655 *
REYNOLDS: "MARTINDALE - THE EXTRA PHARMACOPOEIA.", 1996, ROYAL PHARMACEUTICAL SOCIETY, LONDON, XP002074427, 224540 *
SMITH ET AL.: "Transient immunosuppression permits successful repetitive intravenous administration of an adenovirus vector", GENE THERAPY, vol. 3, no. 6, 1996, pages 496 - 502, XP002076653 *
TEPPER M.A.: "Deoxyspergualin", ANN. N.Y. ACAD. SCI., vol. 696, 1993, pages 123 - 132, XP002076658 *
WAAGA ET AL.: "In Vitro Analysis of the Mode of Action of the Immuno-suppressive Drug 15-Deoxyspergualin", ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS, vol. 44, no. 2-3, 1996, pages 155 - 163, XP002076659 *

Also Published As

Publication number Publication date
WO1998042320A2 (fr) 1998-10-01
DE19711803A1 (de) 1998-09-24
AU7034498A (en) 1998-10-20

Similar Documents

Publication Publication Date Title
WO2003004669A3 (fr) Procede de preparation de l-aminoacides au moyen de souches de la famille des enterobacteriacees
AU2001257004A1 (en) Composite wood product
AU7563800A (en) Marsh-mallow and the marsh-mallow production technique
WO2002046364A8 (fr) Genes associes au stress mecanique, produits d'expression de ces genes et utilisation de ces genes et de leurs produits d'expression
AU6840000A (en) Improvements in or relating to the production of animal feed
WO1997007786A3 (fr) Utilisation de lipides comme adjuvants dans la fabrication de formes medicamenteuses solides selon le procede d'extrusion de matiere fondue
AUPR183100A0 (en) Wood products and processes for the preparation thereof
AU6710198A (en) Stabilized cleansing composition with opacifier
MXPA03000585A (es) Proceso de fermentacion para la preparacion de l-treonina.
EP1079095A3 (fr) Injecteur de combustible
ZA953982B (en) The production of energy-providing fuels
WO1998042320A3 (fr) Prolongation de l'expression de proteines transgeniques par traitement immunomodulant avec de la 15-desoxyspergualine
AU2001280436A1 (en) Process to increase protein stability
AU3824800A (en) Use of tianeptin in the production of medicaments to treat neurodegenerative pathologies
AU3230200A (en) Transgenic plants with modified expression of the dp protein
AU757752C (en) Benzylidene pyrazolones, production and use thereof
AU2002215484A1 (en) Bottles with decorations and the making process thereof
AU1548402A (en) Bottles with decorations and the making process thereof
MX250271B (es) Expresion de proteinas en hongos geneticamente modificados.
USD433267S (en) Four-head electric fryer
ES2181486T3 (es) Recipiente para producto cosmetico y su procedimiento de fabricacion.
AU4645401A (en) Flat composite component and method for the production thereof
USD422465S (en) Apparatus for manufacturing porcelain dolls
AU646941B2 (en) Process for the preparation of 2-pyridylsulfonylureas, and thiadiazoloptridines as intermediates in this process
GB8901269D0 (en) Improvements in or relating to the production of multicoloured flooring

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AL AM AU AZ BA BB BG BR BY CA CN CU CZ EE GE GW HU ID IL IS JP KP KR LC LK LR LS LT LV MG MK MN MX NO NZ PL RO RU SG SI SK SL TR TT UA US UZ VN YU

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AL AM AU AZ BA BB BG BR BY CA CN CU CZ EE GE GW HU ID IL IS JP KP KR LC LK LR LS LT LV MG MK MN MX NO NZ PL RO RU SG SI SK SL TR TT UA US UZ VN YU

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: JP

Ref document number: 1998544817

Format of ref document f/p: F

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: CA

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载